NO320835B1 - Imidazolylderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat - Google Patents

Imidazolylderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat Download PDF

Info

Publication number
NO320835B1
NO320835B1 NO20006401A NO20006401A NO320835B1 NO 320835 B1 NO320835 B1 NO 320835B1 NO 20006401 A NO20006401 A NO 20006401A NO 20006401 A NO20006401 A NO 20006401A NO 320835 B1 NO320835 B1 NO 320835B1
Authority
NO
Norway
Prior art keywords
alkyl
compound
group
formula
approx
Prior art date
Application number
NO20006401A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006401L (no
NO20006401D0 (no
Inventor
Zheng Xin Dong
Yeelana Shen
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20006401L publication Critical patent/NO20006401L/no
Publication of NO20006401D0 publication Critical patent/NO20006401D0/no
Publication of NO320835B1 publication Critical patent/NO320835B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006401A 1998-06-16 2000-12-15 Imidazolylderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat NO320835B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9814198A 1998-06-16 1998-06-16
US8948398P 1998-06-16 1998-06-16
PCT/US1999/013303 WO1999065898A1 (en) 1998-06-16 1999-06-11 Imidazolyl derivatives

Publications (3)

Publication Number Publication Date
NO20006401L NO20006401L (no) 2000-12-15
NO20006401D0 NO20006401D0 (no) 2000-12-15
NO320835B1 true NO320835B1 (no) 2006-01-30

Family

ID=26780620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006401A NO320835B1 (no) 1998-06-16 2000-12-15 Imidazolylderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat

Country Status (12)

Country Link
EP (1) EP1097150B1 (de)
JP (1) JP2002518387A (de)
AR (1) AR019866A1 (de)
AT (1) ATE262520T1 (de)
AU (1) AU4822299A (de)
CA (1) CA2335435A1 (de)
DE (1) DE69915835T2 (de)
DK (1) DK1097150T3 (de)
ES (1) ES2216535T3 (de)
NO (1) NO320835B1 (de)
TW (1) TW577885B (de)
WO (1) WO1999065898A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2825706B1 (fr) * 2001-06-06 2003-12-12 Pf Medicament Nouveaux derives de benzothienyle ou d'indole, leur preparation et leur utilisation comme inhibiteurs de proteines prenyl transferase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
TW316902B (de) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
US5756528A (en) * 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
SK283335B6 (sk) * 1995-12-08 2003-06-03 Janssen Pharmaceutica N. V. (Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
JP2000507590A (ja) * 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質トランスフェラーゼ阻害剤
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles

Also Published As

Publication number Publication date
AR019866A1 (es) 2002-03-20
NO20006401L (no) 2000-12-15
WO1999065898A1 (en) 1999-12-23
AU4822299A (en) 2000-01-05
DK1097150T3 (da) 2004-07-26
TW577885B (en) 2004-03-01
JP2002518387A (ja) 2002-06-25
CA2335435A1 (en) 1999-12-23
NO20006401D0 (no) 2000-12-15
DE69915835T2 (de) 2005-03-24
DE69915835D1 (de) 2004-04-29
ES2216535T3 (es) 2004-10-16
EP1097150B1 (de) 2004-03-24
ATE262520T1 (de) 2004-04-15
EP1097150A1 (de) 2001-05-09

Similar Documents

Publication Publication Date Title
US6133303A (en) Bicyclic inhibitors of protein farnesyl transferase
CN101460466B (zh) 适用作蛋白激酶抑制剂的噻唑类、咪唑类和吡唑类
US7745641B2 (en) Nitrogen-containing heterocyclic compound
KR20070027504A (ko) 테트라졸 화합물 및 대사성 글루타메이트 수용체길항제로서 이들의 용도
CA2170874A1 (en) Azole derivative and pharmaceutical composition thereof
WO2011069298A1 (en) Novel cyclopropane indolinone derivatives
WO2008038841A1 (en) Thiadiazolone derivative and use thereof
CA2053475A1 (en) Quinazoline derivatives and their preparation
EP0686148A1 (de) Inhibitoren der hiv inversen transcriptase
NO318988B1 (no) Ftalazinderivater som fosfodiesterase 4-inhibitorer
KR100204697B1 (ko) 트리아졸릴 치환된 3급 아민 화합물 또는 이의 염
CA2713550C (en) Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
US4617309A (en) Sulfur-containing indole derivatives
US5120749A (en) Platelet activating antagonists
EP1000036A1 (de) Hydantoinderivate mit farnesyltransferase hemmender aktivität
CA2211189A1 (en) Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
US5981529A (en) Substituted indolylpropyl-piperazine derivatives as 5-HT1D α agonists
NO168035B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-((hetero)alkyl)benz(cd)indol-2-aminer.
NO320835B1 (no) Imidazolylderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat
US4347187A (en) Process for preparing 5-aroyl 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
EP0128502A1 (de) Substituierte 6-(Thien-2-yl)-3(2H)-pyridazinone und Verfahren zur Herstellung
US6420555B1 (en) Imidazolyl derivatives
AU2012349288A1 (en) Pyridone derivative and medicine containing same
AU707750B2 (en) Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
US5925638A (en) Substituted 1-indolylpropyl-4-benzylpiperazine derivatives